Clinical Trial to Evaluate ET-01 in Subjects With Lateral Canthal Lines
Phase of Trial: Phase II
Latest Information Update: 08 Jul 2019
Price : $35 *
At a glance
- Drugs Botulinum-Toxin-A (Primary)
- Indications Facial wrinkles
- Focus Therapeutic Use
- Sponsors Eirion Therapeutics
- 01 Jul 2019 Status changed from active, no longer recruiting to completed.
- 07 Feb 2019 Planned End Date changed from 1 Mar 2019 to 1 Apr 2019.
- 07 Feb 2019 Status changed from recruiting to active, no longer recruiting.